BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 35087284)

  • 1. Helminth Therapy for Immune-Mediated Inflammatory Diseases: Current and Future Perspectives.
    Shi W; Xu N; Wang X; Vallée I; Liu M; Liu X
    J Inflamm Res; 2022; 15():475-491. PubMed ID: 35087284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Can Parasites Tell Us About the Pathogenesis and Treatment of Asthma and Allergic Diseases.
    Bohnacker S; Troisi F; de Los Reyes Jiménez M; Esser-von Bieren J
    Front Immunol; 2020; 11():2106. PubMed ID: 33013887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction Between Helminths and Toll-Like Receptors: Possibilities and Potentials for Asthma Therapy.
    Zakeri A; Borji H; Haghparast A
    Int Rev Immunol; 2016 May; 35(3):219-48. PubMed ID: 27120222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant proteins of helminths with immunoregulatory properties and their possible therapeutic use.
    Nascimento Santos L; Carvalho Pacheco LG; Silva Pinheiro C; Alcantara-Neves NM
    Acta Trop; 2017 Feb; 166():202-211. PubMed ID: 27871775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helminth-derived immunomodulatory molecules.
    Adisakwattana P; Saunders SP; Nel HJ; Fallon PG
    Adv Exp Med Biol; 2009; 666():95-107. PubMed ID: 20054978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease.
    Heylen M; Ruyssers NE; Gielis EM; Vanhomwegen E; Pelckmans PA; Moreels TG; De Man JG; De Winter BY
    Pharmacol Ther; 2014 Aug; 143(2):153-67. PubMed ID: 24603369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells: new therapeutic target in helminth immune modulation.
    Vukman KV; Lalor R; Aldridge A; O'Neill SM
    Parasite Immunol; 2016 Jan; 38(1):45-52. PubMed ID: 26577605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helminth therapy (worms) for allergic rhinitis.
    Croft AM; Bager P; Kumar S
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD009238. PubMed ID: 22513973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Potential of Helminths and Helminth-Derived Antigens for Resolution of Inflammation in Inflammatory Bowel Disease.
    Abdoli A
    Arch Med Res; 2019 Jan; 50(1):58-59. PubMed ID: 30879759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can helminths or helminth-derived products be used in humans to prevent or treat allergic diseases?
    Erb KJ
    Trends Immunol; 2009 Feb; 30(2):75-82. PubMed ID: 19138565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helminths and Asthma: Risk and Protection.
    Fernandes JS; Cardoso LS; Pitrez PM; Cruz ÁA
    Immunol Allergy Clin North Am; 2019 Aug; 39(3):417-427. PubMed ID: 31284930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the immunomodulatory components of helminths.
    Shepherd C; Navarro S; Wangchuk P; Wilson D; Daly NL; Loukas A
    Parasite Immunol; 2015 Jun; 37(6):293-303. PubMed ID: 25854639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prerequisites for the pharmaceutical industry to develop and commercialise helminths and helminth-derived product therapy.
    Tilp C; Kapur V; Loging W; Erb KJ
    Int J Parasitol; 2013 Mar; 43(3-4):319-25. PubMed ID: 23291462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helminths and the microbiota: parts of the hygiene hypothesis.
    Loke P; Lim YA
    Parasite Immunol; 2015 Jun; 37(6):314-23. PubMed ID: 25869420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis.
    Pineda MA; Al-Riyami L; Harnett W; Harnett MM
    Clin Exp Immunol; 2014 Jul; 177(1):13-23. PubMed ID: 24666108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Consistent Association between Asthma, Allergic Diseases, and Intestinal Helminth Infection in School-Aged Children in the Province of Bengo, Angola.
    Arrais M; Lulua O; Quifica F; Rosado-Pinto J; Gama JMR; Cooper PJ; Taborda-Barata L; Brito M
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34200291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helminths: Immunoregulation and Inflammatory Diseases-Which Side Are Trichinella spp. and Toxocara spp. on?
    Aranzamendi C; Sofronic-Milosavljevic L; Pinelli E
    J Parasitol Res; 2013; 2013():329438. PubMed ID: 23365718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of helminths in autoimmune diseases: helminth-derived immune-regulators and immune balance.
    Wang M; Wu L; Weng R; Zheng W; Wu Z; Lv Z
    Parasitol Res; 2017 Aug; 116(8):2065-2074. PubMed ID: 28664463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
    Bellinger DL; Lorton D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parasites-allergy paradox: Disease mediators or therapeutic modulators.
    Afifi MA; Jiman-Fatani AA; El Saadany S; Fouad MA
    J Microsc Ultrastruct; 2015; 3(2):53-61. PubMed ID: 30023182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.